Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry
CONCLUSIONS: ViV TAVI using either ACURATE or Evolut THVs showed similar procedural outcomes. However, a true ID >19 mm was associated with higher device success among ACURATE recipients, whereas in patients with a true ID ≤19 mm, device success was higher when using Evolut.PMID:38506737 | PMC:PMC10941672 | DOI:10.4244/EIJ-D-23-00779
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Authors: Won-Keun Kim Moritz Seiffert Andreas R ück David M Leistner Henryk Dreger Hendrik Wienemann Matti Adam Helge M öllmann Johannes Blumenstein Clemens Eckel Andrea Buono Diego Maffeo Antonio Messina Andreas Holzamer Samuel Sossalla Giuliano Costa Marco Bar Source Type: research
More News: Academia | Cardiology | Cardiovascular & Thoracic Surgery | Heart | Heart Valve Disease | Heart Valves | Study